In the peripheral nervous system (PNS), pharmacological inhibition of GCPII has demonstrated the preservation of nerve structure and function in models of chemotherapy-induced neurotoxicity and diabetic neuropathy [37,38]. The gene discussed is FOLH1; the disease is diabetic neuropathy.